Application no. and date | 19202854.6 (espacenet) (Federated) (European Patent Register), 20140826 | Patent/reg. no. and date | DK/EP 3626270, 20231011 | Publication date | 20200325 | Priority no. and date | WO PCT/US2013/056680, 20130826, US 201461972933 P, 20140331 | EP pub. no. and date |
EP 3626270 20200325 | Effective date | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | Applicant ref. no. | 169132/BT/GP | Inventor | LEFKOWITZ, Martin, Novartis Pharmaceuticals Corporation One Health Plaza
East Hanover, New Jersey 07936, US, SHI, Victor Chengwei, Novartis Pharmaceuticals Corporation One Health Plaza
East Hanover, New Jersey 07936, US, RIZKALA, Adel Remond, Novartis Pharmaceuticals Corporation One Health Plaza
East Hanover, New Jersey 07936, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 31/194 (2006.01) , A61K 31/197 (2006.01) , A61K 31/216 (2006.01) , A61K 31/221 (2006.01) , A61K 31/225 (2006.01) , A61K 31/401 (2006.01) , A61K 31/41 (2006.01) , A61K 45/06 (2006.01) , A61P 9/10 (2006.01) , A61P 9/12 (2006.01) | Title | BEHANDLING AF KARDIOVASKULÆRE SYGDOMME | Int. application no. | | Int. publication no. | | Related patent (certificate) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|